Curis
CRIS
#10632
Rank
โ‚น1.18 B
Marketcap
โ‚น30.28
Share price
55.98%
Change (1 day)
-84.73%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น346.15. In 2024 the company made an earnings per share (EPS) of -โ‚น663.07 an increase over its 2023 EPS that were of -โ‚น851.71.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-52.36%
2024-โ‚น663.07-22.15%
2023-โ‚น851.71-26.17%
2022-โ‚น1,15422.3%
2021-โ‚น943.20-25.37%
2020-โ‚น1,264-30.93%
2019-โ‚น1,830-2.02%
2018-โ‚น1,868
2016-โ‚น4,244-10%
2015-โ‚น4,716138.1%
2014-โ‚น1,98140%
2013-โ‚น1,415-25%
2012-โ‚น1,88666.67%
2011-โ‚น1,132

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น123.56-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น335.78-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.96-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น295.22-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น366.90 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,060 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น132.99-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA